Legal & General Group’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-158,314
| Closed | -$3.76M | – | 3409 |
|
|
2023
Q3 | $3.76M | Sell |
158,314
-3,538
| -2% | -$66.6K | ﹤0.01% | 1598 |
|
|
2023
Q2 | $2.63M | Sell |
161,852
-3,274
| -2% | -$54.2K | ﹤0.01% | 1792 |
|
|
2023
Q1 | $2.87M | Sell |
165,126
-1,051
| -0.6% | -$18.9K | ﹤0.01% | 1709 |
|
|
2022
Q4 | $3.12M | Buy |
166,177
+2,543
| +2% | +$49K | ﹤0.01% | 1665 |
|
|
2022
Q3 | $2.9M | Sell |
163,634
-1,436
| -0.9% | -$24.9K | ﹤0.01% | 1666 |
|
|
2022
Q2 | $2.88M | Sell |
165,070
-846
| -0.5% | -$16.1K | ﹤0.01% | 1696 |
|
|
2022
Q1 | $3.47M | Sell |
165,916
-1,566
| -0.9% | -$30K | ﹤0.01% | 1723 |
|
|
2021
Q4 | $2.98M | Buy |
167,482
+6,555
| +4% | +$105K | ﹤0.01% | 1841 |
|
|
2021
Q3 | $2.27M | Buy |
160,927
+13,221
| +9% | +$206K | ﹤0.01% | 1965 |
|
|
2021
Q2 | $2.45M | Sell |
147,706
-36,620
| -20% | -$656K | ﹤0.01% | 1877 |
|
|
2021
Q1 | $3.34M | Buy |
184,326
+1,828
| +1% | +$36.1K | ﹤0.01% | 1765 |
|
|
2020
Q4 | $3.33M | Buy |
182,498
+158
| +0.1% | +$2.51K | ﹤0.01% | 1680 |
|
|
2020
Q3 | $2.32M | Buy |
182,340
+33,252
| +22% | +$425K | ﹤0.01% | 1701 |
|
|
2020
Q2 | $1.64M | Buy |
149,088
+9,038
| +6% | +$93.6K | ﹤0.01% | 1804 |
|
|
2020
Q1 | $1.46M | Sell |
140,050
-132
| -0.1% | -$1.7K | ﹤0.01% | 1717 |
|
|
2019
Q4 | $2.25M | Buy |
140,182
+9,178
| +7% | +$152K | ﹤0.01% | 1748 |
|
|
2019
Q3 | $2.05M | Buy |
131,004
+5,975
| +5% | +$99.4K | ﹤0.01% | 1712 |
|
|
2019
Q2 | $2.49M | Sell |
125,029
-972
| -0.8% | -$18.2K | ﹤0.01% | 1603 |
|
|
2019
Q1 | $2.12M | Buy |
126,001
+11,474
| +10% | +$199K | ﹤0.01% | 1678 |
|
|
2018
Q4 | $1.74M | Buy |
114,527
+416
| +0.4% | +$7.14K | ﹤0.01% | 1648 |
|
|
2018
Q3 | $2.28M | Buy |
114,111
+8,327
| +8% | +$177K | ﹤0.01% | 1643 |
|
|
2018
Q2 | $2.08M | Buy |
105,784
+5,849
| +6% | +$92.4K | ﹤0.01% | 1648 |
|
|
2018
Q1 | $1.36M | Buy |
99,935
+2,140
| +2% | +$28.2K | ﹤0.01% | 1780 |
|
|
2017
Q4 | $1.33M | Buy |
97,795
+4,675
| +5% | +$67.1K | ﹤0.01% | 1783 |
|
|
2017
Q3 | $1.46M | Buy |
93,120
+3,164
| +4% | +$51.1K | ﹤0.01% | 1719 |
|
|
2017
Q2 | $1.55M | Buy |
89,956
+12,721
| +16% | +$193K | ﹤0.01% | 1661 |
|
|
2017
Q1 | $1.18M | Sell |
77,235
-379
| -0.5% | -$5.58K | ﹤0.01% | 1734 |
|
|
2016
Q4 | $1.02M | Buy |
77,614
+38,559
| +99% | +$494K | ﹤0.01% | 1731 |
|
|
2016
Q3 | $441K | Buy |
39,055
+30,744
| +370% | +$369K | ﹤0.01% | 1749 |
|
|
2016
Q2 | $97K | Hold |
8,311
| – | – | ﹤0.01% | 2109 |
|
|
2016
Q1 | $128K | Buy |
8,311
+1,092
| +15% | +$16.6K | ﹤0.01% | 1912 |
|
|
2015
Q4 | $119K | Hold |
7,219
| – | – | ﹤0.01% | 1976 |
|
|
2015
Q3 | $89K | Hold |
7,219
| – | – | ﹤0.01% | 2112 |
|
|
2015
Q2 | $120K | Hold |
7,219
| – | – | ﹤0.01% | 1988 |
|
|
2015
Q1 | $116K | Hold |
7,219
| – | – | ﹤0.01% | 1941 |
|
|
2014
Q4 | $114K | Hold |
7,219
| – | – | ﹤0.01% | 1877 |
|
|
2014
Q3 | $101K | Buy |
+7,219
| New | +$110K | ﹤0.01% | 1881 |
|
Other funds holding NXGN
Legal & General Group's NXGN Position: Q4 2023 in Review
Legal & General Group sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2023, closing a stake of 158,314 shares — an estimated $3.76M sold.
Legal & General Group first reported a position in NXGN in Q3 2014 and held it in 37 quarters. The position peaked at $3.76M in Q3 2023. 1 fund tracked by Wall St. Rank holds NXGN as of Q4 2023.
- Legal & General Group reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Legal & General Group sold 158,314 NextGen Healthcare, Inc. Common Stock shares in Q4 2023, an estimated $3.76M.
- Legal & General Group first reported a position in NextGen Healthcare, Inc. Common Stock in Q3 2014 and held it in 37 quarters.
- Legal & General Group's NextGen Healthcare, Inc. Common Stock position peaked at $3.76M in Q3 2023.
- 1 fund tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2023.
Based on Legal & General Group's 13F filing for Q4 2023, filed 15 Feb 2024.